Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Shi Ming, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01869088
First received: February 16, 2013
Last updated: December 6, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Publications: